Amneal Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
AMRX
CUSIP
03168L105
All holders as of
Q2 2026
Type
Equity
Class
COM STK CL A
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 03168L105 since 12/18/2024, largest first.

Filer % of Class Filed
Patel Tushar Bhikhubhai 13D/A 17.6% 8/12/2026
Event 8/10/2026
Chintu Patel 13D/A 9.4% 8/12/2026
Event 8/10/2026
Patel Chirag K. 13D/A 8.4% 8/12/2026
Event 8/10/2026
BlackRock, Inc. 13G 7.6% 4/27/2026
Event 3/31/2026
Akram Mahesh 13G/A 6.6% 5/14/2025
Event 3/31/2025
Patel Dipan 13D/A 5.4% 3/26/2026
Event 12/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026
UBS Group AG 13G/A
Checked 5% or less
2/10/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 174 35.4 M $712M
2026 Q2 313 164 M $2.83B
2026 Q1 319 161 M $2.00B
2025 Q4 279 155 M $1.95B
2025 Q3 248 151 M $1.51B
2025 Q2 242 143 M $1.16B
2025 Q1 239 136 M $1.14B
2024 Q4 201 126 M $999M
2024 Q3 185 143 M $1.19B
2024 Q2 184 139 M $874M
2024 Q1 177 108 M $651M
2023 Q4 154 109 M $663M
2023 Q3 145 102 M $430M
2023 Q2 129 97.5 M $302M
2023 Q1 146 96.9 M $135M
2022 Q4 158 102 M $205M
2022 Q3 156 99.6 M $203M
2022 Q2 154 99.4 M $316M
2022 Q1 169 100 M $417M
2021 Q4 155 101 M $481M
2021 Q3 155 100 M $535M
2021 Q2 161 99.9 M $512M
2021 Q1 163 102 M $684M
2020 Q4 135 99.5 M $455M
2020 Q3 142 101 M $394M
2020 Q2 140 102 M $484M
2020 Q1 129 98.3 M $342M
2019 Q4 131 101 M $488M
2019 Q3 123 108 M $314M
2019 Q2 131 106 M $757M
2019 Q1 166 109 M $1.55B
2018 Q4 169 116 M $1.57B
2018 Q3 170 109 M $2.41B
2018 Q2 166 97.6 M $1.60B